JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Fulton Financial
FULT
$4.63B
| $32.9M | 0.01% |
1,840,426
+26,638
| +1% | +$490K |
|
|
1202
PUT
Johnson & Johnson
JNJ
$625B
| $32.9M | 0.01% |
235,200
+184,900
| +368% | +$25.8M |
|
|
LOGM
1203
DELISTED
LogMein, Inc.
LOGM
| $32.9M | 0.01% |
286,916
-43,265
| -13% | -$5.08M |
|
1204
Hormel Foods
HRL
$13.6B
| $32.8M | 0.01% |
901,512
+728,247
| +420% | +$24.5M |
|
1205
CALL
Gilead Sciences
GILD
$165B
| $32.8M | 0.01% |
457,600
-980,000
| -68% | -$74.4M |
|
1206
Enbridge
ENB
$112B
| $32.7M | 0.01% |
836,725
+3,618
| +0.4% | +$139K |
|
1207
PUT
HP
HPQ
$27.6B
| $32.7M | 0.01% |
1,556,500
+76,500
| +5% | +$1.63M |
|
1208
Spire
SR
$4.82B
| $32.7M | 0.01% |
434,646
+16,518
| +4% | +$1.28M |
|
1209
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.4B
| $32.7M | 0.01% |
132,000
+32,000
| +32% | +$7.58M |
|
1210
Huron Consulting
HURN
$2.43B
| $32.6M | 0.01% |
805,813
+5,022
| +0.6% | +$193K |
|
1211
Expeditors International
EXPD
$23.2B
| $32.5M | 0.01% |
502,922
+5,839
| +1% | +$358K |
|
|
AET
1212
CALL
DELISTED
Aetna Inc
AET
| $32.4M | 0.01% |
179,600
+117,100
| +187% | +$20.1M |
|
1213
Chemours
CC
$2.26B
| $32.4M | 0.01% |
646,584
-1,554,703
| -71% | -$81.4M |
|
|
AAN.A
1214
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $32.3M | 0.01% |
811,644
-117,491
| -13% | -$4.68M |
|
1215
Idacorp
IDA
$8.13B
| $32.2M | 0.01% |
352,949
+36,763
| +12% | +$3.44M |
|
|
STOR
1216
DELISTED
STORE Capital Corporation
STOR
| $32.1M | 0.01% |
1,234,149
+725,191
| +142% | +$18.6M |
|
1217
PUT
XPO
XPO
$23.5B
| $32.1M | 0.01% |
1,011,988
+144,570
| +17% | +$3.7M |
|
1218
PUT
Verizon
VZ
$193B
| $32M | 0.01% |
604,800
-59,400
| -9% | -$2.92M |
|
|
EEX
1219
DELISTED
Emerald Holding
EEX
| $32M | 0.01% |
1,573,504
-88,070
| -5% | -$1.95M |
|
1220
Bank of Hawaii
BOH
$3.1B
| $32M | 0.01% |
372,885
-2,720
| -0.7% | -$227K |
|
1221
iShares Russell 3000 ETF
IWV
$20.5B
| $31.9M | 0.01% |
201,886
+20,866
| +12% | +$3.22M |
|
1222
United States Oil Fund
USO
$1.74B
| $31.9M | 0.01% |
331,728
-37,836
| -10% | -$3.36M |
|
1223
Prudential
PUK
$35.3B
| $31.8M | 0.01% |
646,466
+26,363
| +4% | +$1.26M |
|
1224
Dillards
DDS
$9.74B
| $31.8M | 0.01% |
529,041
-81,679
| -13% | -$4.53M |
|
|
1225
CALL
Verizon
VZ
$193B
| $31.8M | 0.01% |
600,200
-717,900
| -54% | -$35.3M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.